European Network of Excellence for Big Data in Hematology. Funded by the Innovative Medicines Initiative. Read more
Registration of novel drug compounds is increasingly difficult, costly, and time-consuming, thus preventing patients from receiving the right treatment in time. Patients with hematologic malignancies (HMs) have unmet needs that must be addressed. Read more
51 Partners sharing the same goal: use ‘big data’ technologies to deliver information that will help to improve the care of patients with hematological malignancies: Introducing the HARMONY Alliance. Read more
Europe's largest public-private partnership aiming to improve the outcomes of patients with hematological malignancies through the use of big data sharing among all relevant stakeholders involved.
The HARMONY Alliance is an unparalleled medicine offensive to battle blood cancers by using Big Data analyses. One of the most important milestones that was jointly achieved in the first year of HARMONY, is the establishment of HARMONY’s Big Data platform. Public and private organizations will contribute data on most hematological cancers.Read more
November 27, 2017